402 related articles for article (PubMed ID: 36441472)
1. Non-alcoholic fatty liver disease and liver secretome.
Khan MS; Lee C; Kim SG
Arch Pharm Res; 2022 Dec; 45(12):938-963. PubMed ID: 36441472
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of endoplasmic reticulum-related and secretome gene expression profiles in the progression of non-alcoholic fatty liver disease.
Gao R; Wang J; He X; Wang T; Zhou L; Ren Z; Yang J; Xiang X; Wen S; Yu Z; Ai H; Wang Y; Liang H; Li S; Lu Y; Zhu Y; Shi G; Chen Y
Front Endocrinol (Lausanne); 2022; 13():967016. PubMed ID: 36034446
[TBL] [Abstract][Full Text] [Related]
3. Endoplasmic reticulum stress in nonalcoholic (metabolic associated) fatty liver disease (NAFLD/MAFLD).
Flessa CM; Kyrou I; Nasiri-Ansari N; Kaltsas G; Kassi E; Randeva HS
J Cell Biochem; 2022 Oct; 123(10):1585-1606. PubMed ID: 35490371
[TBL] [Abstract][Full Text] [Related]
4. FOXA3 induction under endoplasmic reticulum stress contributes to non-alcoholic fatty liver disease.
Liu C; Zhou B; Meng M; Zhao W; Wang D; Yuan Y; Zheng Y; Qiu J; Li Y; Li G; Xiong X; Bian H; Zhang H; Wang H; Ma X; Hu C; Xu L; Lu Y
J Hepatol; 2021 Jul; 75(1):150-162. PubMed ID: 33548387
[TBL] [Abstract][Full Text] [Related]
5. Endoplasmic reticulum stress and autophagy dysregulation in alcoholic and non-alcoholic liver diseases.
Kim YS; Kim SG
Clin Mol Hepatol; 2020 Oct; 26(4):715-727. PubMed ID: 32951410
[TBL] [Abstract][Full Text] [Related]
6. Endoplasmic Reticulum Stress and Autophagy in the Pathogenesis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Evidence and Perspectives.
Flessa CM; Kyrou I; Nasiri-Ansari N; Kaltsas G; Papavassiliou AG; Kassi E; Randeva HS
Curr Obes Rep; 2021 Jun; 10(2):134-161. PubMed ID: 33751456
[TBL] [Abstract][Full Text] [Related]
7. Endoplasmic Reticulum Stress Related Molecular Mechanisms in Nonalcoholic Fatty Liver Disease (NAFLD).
Wang L; Chen J; Ning C; Lei D; Ren J
Curr Drug Targets; 2018; 19(9):1087-1094. PubMed ID: 29766802
[TBL] [Abstract][Full Text] [Related]
8. Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease.
Svegliati-Baroni G; Pierantonelli I; Torquato P; Marinelli R; Ferreri C; Chatgilialoglu C; Bartolini D; Galli F
Free Radic Biol Med; 2019 Nov; 144():293-309. PubMed ID: 31152791
[TBL] [Abstract][Full Text] [Related]
9. Non-Alcoholic Fatty Liver Disease.
Engin A
Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of NASH: How Metabolic Complications of Overnutrition Favour Lipotoxicity and Pro-Inflammatory Fatty Liver Disease.
Farrell GC; Haczeyni F; Chitturi S
Adv Exp Med Biol; 2018; 1061():19-44. PubMed ID: 29956204
[TBL] [Abstract][Full Text] [Related]
11. The adaptive endoplasmic reticulum stress response to lipotoxicity in progressive human nonalcoholic fatty liver disease.
Lake AD; Novak P; Hardwick RN; Flores-Keown B; Zhao F; Klimecki WT; Cherrington NJ
Toxicol Sci; 2014 Jan; 137(1):26-35. PubMed ID: 24097666
[TBL] [Abstract][Full Text] [Related]
12. Treatment with didemnin B, an elongation factor 1A inhibitor, improves hepatic lipotoxicity in obese mice.
Hetherington AM; Sawyez CG; Sutherland BG; Robson DL; Arya R; Kelly K; Jacobs RL; Borradaile NM
Physiol Rep; 2016 Sep; 4(17):. PubMed ID: 27613825
[TBL] [Abstract][Full Text] [Related]
13. Resolvin D3 improves the impairment of insulin signaling in skeletal muscle and nonalcoholic fatty liver disease through AMPK/autophagy-associated attenuation of ER stress.
Oh H; Cho W; Abd El-Aty AM; Bayram C; Jeong JH; Jung TW
Biochem Pharmacol; 2022 Sep; 203():115203. PubMed ID: 35948170
[TBL] [Abstract][Full Text] [Related]
14. Endoplasmic reticulum stress related molecular mechanisms in nonalcoholic steatohepatitis.
Bozaykut P; Sahin A; Karademir B; Ozer NK
Mech Ageing Dev; 2016 Jul; 157():17-29. PubMed ID: 27393639
[TBL] [Abstract][Full Text] [Related]
15. Vitexin Attenuates Non-alcoholic Fatty Liver Disease Lipid Accumulation in High Fat-Diet Fed Mice by Activating Autophagy and Reducing Endoplasmic Reticulum Stress in Liver.
Jiang Y; Gong Q; Gong Y; Zhuo C; Huang J; Tang Q
Biol Pharm Bull; 2022 Mar; 45(3):260-267. PubMed ID: 35034930
[TBL] [Abstract][Full Text] [Related]
16. How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
Geng Y; Faber KN; de Meijer VE; Blokzijl H; Moshage H
Hepatol Int; 2021 Feb; 15(1):21-35. PubMed ID: 33548031
[TBL] [Abstract][Full Text] [Related]
17. Critical Role of NFκB in the Pathogenesis of Non-alcoholic Fatty Liver Disease: A Widespread Key Regulator.
Franceschetti L; Bonomini F; Rodella LF; Rezzani R
Curr Mol Med; 2021; 21(6):495-505. PubMed ID: 33106141
[TBL] [Abstract][Full Text] [Related]
18. Elevation of liver endoplasmic reticulum stress in a modified choline-deficient l-amino acid-defined diet-fed non-alcoholic steatohepatitis mouse model.
Muraki Y; Makita Y; Yamasaki M; Amano Y; Matsuo T
Biochem Biophys Res Commun; 2017 May; 486(3):632-638. PubMed ID: 28322783
[TBL] [Abstract][Full Text] [Related]
19. The relationship between endoplasmic reticulum stress and liver function, insulin resistance and vascular endothelial function in patients with non-alcoholic fatty liver disease.
Zhou SL; Li C; Huang JJ; Xiong Q; Li QZ; Peng BK; Tang Z
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11707-11715. PubMed ID: 33275239
[TBL] [Abstract][Full Text] [Related]
20. Ginsenoside Rg1 Protects against Non-alcoholic Fatty Liver Disease by Ameliorating Lipid Peroxidation, Endoplasmic Reticulum Stress, and Inflammasome Activation.
Xu Y; Yang C; Zhang S; Li J; Xiao Q; Huang W
Biol Pharm Bull; 2018 Nov; 41(11):1638-1644. PubMed ID: 30135326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
